Abstract
This review presents recent data on one of the most promising neuroimaging techniques, pharmacological functional magnetic resonance imaging (phFMRI). PhFMRI technologies are described as well as task-based approaches inducing neuronal activation in the areas of interest when evaluating the effects of neuroactive agents. We reviewed the potential use of phFMRI in various neurological disorders such as cerebrovascular disease and epilepsy, as well as in the management of metabolic disorders, cognitive impairment, pain syndrome, etc. Limitations of phFMRI and possible ways to address them in designing and conducting studies are presented. The potential uses of phFMRI for the objective assessment of the targeted effects of pharmacological agents are suggested.
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have